Health Care › Laboratory Analytical Instruments

WAT Price Correlated With Financials For Waters

Free historical financial statements for Waters Corp.. See how revenue, income, cash flow, and balance sheet financials have changed over 52 quarters since 2010. Compare with WAT stock chart to see long term trends.

WAT Stock Compared to Quarterly

log linear

WAT Income Statement

Revenue, Net:

Revenue Per Share:

Cost of Goods & Services Sold:

Gross Profit:

Selling, General & Admin Expense:

Research & Development Expense:

Total Operating Expenses:

Operating Income:

Income Taxes:

Net Income:

Earnings Per Share, Diluted:

Earnings Per Share, Basic:

Shares Outstanding, Basic Avg:

Shares Outstanding, Diluted Avg:

Common Stock Shares Outstanding:

WAT Cash Flow

Operating Activities Net Income:

Depreciation, Depletion & Amortization:

Change in Accounts Receiveable:

Net Cash from Operations:

Net Cash from Operations Per Share:

Repurchases/Buybacks Common Stock:

Issuance of Long-term Debt:

Cash Dividends Paid:

Net Cash from Financing Activities:

Property, Plant & Equipment Purchases:

Purchases of Businesses, Net of Cash:

Net Cash from Investing Activities:

Net Change in Cash & Equivalents:

WAT Balance Sheet

Cash and Cash Equivalents:

Short-Term Investments:

Accounts Receivable, Net:

Inventories:

Total Current Assets:

Property, Plant & Equipment, Net:

Total Assets:

Accounts Payable:

Current Portion of Long-Term Debt:

Total Short-Term Liabilities:

Long Term Debt, Non-Current Portion:

Total Long-Term Liabilities:

Total Liabilities:

Insider Trading

Change

Value

Transaction

SEC Form 4

VERGNANO MARK P Director

3,185 sh at $313

$997,927

Buy

2023-03-01

Major Holders (from 13F filings)

Investment Type

Change

Value (x$1000)

increase or decrease

Blackrock.

6,587,122 sh

90,715 sh
1%

$2,256,616,118

$2,254,865,144

Fundsmith

3,689,697 sh

-3,500 sh
0%

$1,264,016

$268,589

Bank Of New York Mellon

3,488,744 sh

3,488,744 sh
NEW

$1,195,174

Massachusetts Financial Services /Ma/

2,656,408 sh

32,682 sh
1%

$910,032,253

$909,325,079

State Street

2,626,546 sh

-33,808 sh
-1%

$899,802

$182,757

Geode Capital Management

1,196,875 sh

21,706 sh
2%

$409,265

$92,900

Wellington Management Group Llp

1,101,566 sh

-222,740 sh
-17%

$377,374,481

$377,017,541

FUNDSMITH INVESTMENT SERVICES LTD.

835,238 sh

12,421 sh
2%

$286,136

$64,362

Morgan Stanley

802,584 sh

414,334 sh
107%

$274,949

$170,303

Northernrp

773,600 sh

6,536 sh
1%

$265,019,888

$264,813,141

Citadel Advisors

770,742 sh

750,842 sh
3773%

$264,041

$258,677

Champlain Investment Partners

748,509 sh

-9,236 sh
-1%

$256,424,213

$256,219,978

Invesco.

682,802 sh

-237,839 sh
-26%

$233,914,311

$233,666,169

FMR

666,275 sh

242,454 sh
57%

$228,252,334

$228,138,102

Norges Bank

630,454 sh

630,454 sh
NEW

$215,981

Legal & General Group Plc

616,013 sh

-24,468 sh
-4%

$211,033

$38,403

Mawer Investment Management.

600,017 sh

3,267 sh
1%

$205,553,824

$205,392,982

American Century Companies

541,302 sh

7,455 sh
1%

$185,439,239

$185,295,351

Nuveen Asset Management

505,457 sh

190,128 sh
60%

$174

-$84,817

Millennium Management

473,565 sh

470,565 sh
15686%

$162

-$647

COMPANY PROFILE

1 Description of Business and Organization

Waters Corporation (the “Company,” “we,” “our,” or “us”) is a specialty measurement company that operates with a fundamental underlying purpose to advance the science that enables our customers to enhance human health and well-being. The Company has pioneered analytical workflow solutions involving liquid chromatography, mass spectrometry and thermal analysis innovations serving the life, materials and food sciences for more than 60 years. The Company primarily designs, manufactures, sells and services high performance liquid chromatography (“HPLC”), ultra performance liquid chromatography (“UPLC TM

” and together with HPLC, referred to as “LC”) and mass spectrometry (“MS”) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. These systems are complementary products that are frequently employed together (“LC-MS”)

and sold as integrated instrument systems using common software platforms. LC is a standard technique and is utilized in a broad range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify a full range of compounds. MS technology, principally in conjunction with chromatography, is employed in drug discovery and development, including clinical trial testing, the analysis of proteins in disease processes (known as “proteomics”), nutritional safety analysis and environmental testing. LC-MS

instruments combine a liquid phase sample introduction and separation system with mass spectrometric compound identification and quantification. In addition, the Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA TM

product line. These instruments are used in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals and viscous liquids for various industrial, consumer goods and healthcare products, as well as for life science research. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments.

Data imported from Waters Corp. SEC filings. Check original filings before making any investment decision.